{"schema_version":"secwatch.filing_event.v1","accession":"0001326190-25-000053","form_type":"8-K","ticker":"ALT","cik":"0001326190","company_name":"Altimmune, Inc.","filed_at":"2025-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.109321+00:00","generated_at":"2026-05-17T04:42:53.441319+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Altimmune appoints Christophe Arbet-Engels as CMO; Dr. Scott Harris to retire as Senior Strategic Advisor by Feb 2026","bullets":["Dr. Scott Harris stepped down as CMO effective Oct 1, 2025; will serve as Senior Strategic Advisor until retirement on Feb 28, 2026.","Christophe Arbet-Engels, MD, PhD joined as CMO effective Oct 1, 2025.","Transition Agreement provides Harris continued salary, benefits, equity vesting, and FY2025 bonus eligibility subject to release and compliance.","Harris's stock option exercise period extended to 12 months after separation date."],"urls":{"canonical":"https://secwatch.observer/filing/0001326190-25-000053","json":"https://secwatch.observer/filing/0001326190-25-000053.json","markdown":"https://secwatch.observer/filing/0001326190-25-000053.md","text":"https://secwatch.observer/filing/0001326190-25-000053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326190/000132619025000053/0001326190-25-000053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326190/000132619025000053/alt-20251001x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:42:53.441319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}